The trend of cutaneous lesions during COVID-19 pandemic: lessons from a meta-analysis and systematic review.
Bandhala Rajan MPraveen Kumar-MAbhishek BhardwajPublished in: International journal of dermatology (2020)
The estimated prevalence of cutaneous manifestations in COVID-19 was 5.69%. Other manifestations were urticaria, chilblain-like lesions, livedo reticularis, and finger/toe gangrene. Although it is premature to conclude the prevalence of the cutaneous manifestations during this ongoing pandemic, our report may be a stimulating factor for the physicians to perform further vigilant streamlined reporting of cutaneous manifestations in COVID-19 patients to estimate the final prevalence.